Treatment to cure: Advancing AAV gene therapy manufacture
Author:
- 9 May 2023
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 28 (7) , 103610
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Manufacturing of recombinant adeno-associated viral vectors for clinical trialsMolecular Therapy - Methods & Clinical Development, 2016
- Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial ScaleHuman Gene Therapy, 2015
- Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success—A Personal PerspectiveHuman Gene Therapy, 2015
- The history of monoclonal antibody development - Progress, remaining challenges and future innovationsAnnals of Medicine & Surgery, 2014
- AAV-Mediated Gene Therapy for Research and Therapeutic PurposesAnnual Review of Virology, 2014
- Adeno-Associated Virus Structural Biology as a Tool in Vector DevelopmentFuture Virology, 2013
- Efficient Serotype-Dependent Release of Functional Vector into the Culture Medium During Adeno-Associated Virus ManufacturingHuman Gene Therapy, 2010
- Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulationMolecular Therapy, 2005
- Feasibility of Generating Adeno-Associated Virus Packaging Cell Lines Containing Inducible Adenovirus Helper GenesJournal of Virology, 2002
- Nucleic acid from an adeno-associated virus: chemical and physical studies.Proceedings of the National Academy of Sciences, 1966